Question 1

Is Adrenaline-(Epinephrine)-Acid-Tartrate currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Adrenaline-(Epinephrine)-Acid-Tartrate has 6 active shortage notices across 5 countries (Australia, United States, Norway, Ireland, Netherlands). Status is refreshed daily from official regulatory sources.

Question 2

Why is Adrenaline-(Epinephrine)-Acid-Tartrate in shortage?

Accepted Answer

Regulators attribute the current Adrenaline-(Epinephrine)-Acid-Tartrate shortages to unexpected increases in demand, supply-chain disruption, product discontinuation. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Adrenaline-(Epinephrine)-Acid-Tartrate shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 15 Sept 2026 to 18 Dec 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this Adrenaline-(Epinephrine)-Acid-Tartrate shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.

Country	Severity	Notices	Since	Est. resolution	Source
Australia	critical	2	25 Jul 2025	18 Dec 2026	TGA
United States	critical	1	20 Dec 2024	—	FDA MedWatch

Adrenaline-(Epinephrine)-Acid-Tartrate shortage status

Where Adrenaline-(Epinephrine)-Acid-Tartrate is in shortage

Why Adrenaline-(Epinephrine)-Acid-Tartrate is in shortage

Recent shortage history

Frequently asked questions

Get alerted when Adrenaline-(Epinephrine)-Acid-Tartrate status changes